Form 8-K - Current report:
SEC Accession No. 0000950170-21-001559
Filing Date
2021-08-25
Accepted
2021-08-25 16:11:21
Documents
14
Period of Report
2021-08-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crbu-20210824.htm   iXBRL 8-K 51097
2 EX-99.1 crbu-20210824ex99_1.htm EX-99.1 18893
3 GRAPHIC img147261482_0.jpg GRAPHIC 52289
  Complete submission text file 0000950170-21-001559.txt   265323

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crbu-20210824_lab.xml EX-101.LAB 13486
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crbu-20210824.xsd EX-101.SCH 2435
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crbu-20210824_pre.xml EX-101.PRE 9980
7 EXTRACTED XBRL INSTANCE DOCUMENT crbu-20210824_htm.xml XML 4719
Mailing Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710
Business Address 2929 7TH STREET, SUITE 105 BERKELEY CA 94710 510-982-6030
Caribou Biosciences, Inc. (Filer) CIK: 0001619856 (see all company filings)

EIN.: 453728228 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40631 | Film No.: 211207021
SIC: 2836 Biological Products, (No Diagnostic Substances)